| Key Financial Ratios of Lincoln Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
41.11 |
46.58 |
36.40 |
34.63 |
30.20 |
|
| Diluted EPS (Rs.) |
41.11 |
46.58 |
36.40 |
34.63 |
30.20 |
|
| Cash EPS (Rs.) |
47.55 |
51.89 |
40.97 |
38.66 |
33.04 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
335.34 |
295.98 |
250.86 |
216.12 |
182.48 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
335.34 |
295.98 |
250.86 |
216.12 |
182.48 |
|
| Dividend / Share(Rs.) |
1.80 |
1.80 |
1.50 |
1.50 |
1.50 |
|
| Revenue from Operations/Share (Rs.) |
311.15 |
289.84 |
254.78 |
235.69 |
206.53 |
|
| PBDIT/Share (Rs.) |
61.89 |
67.07 |
55.74 |
52.66 |
44.06 |
|
| PBIT/Share (Rs.) |
55.45 |
61.76 |
51.17 |
48.62 |
41.23 |
|
| PBT/Share (Rs.) |
54.51 |
61.03 |
50.15 |
47.89 |
40.51 |
|
| Net Profit/Share (Rs.) |
41.11 |
46.58 |
36.40 |
34.63 |
30.20 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
19.89 |
23.13 |
21.87 |
22.34 |
21.33 |
|
| PBIT Margin (%) |
17.82 |
21.30 |
20.08 |
20.62 |
19.96 |
|
| PBT Margin (%) |
17.51 |
21.05 |
19.68 |
20.32 |
19.61 |
|
| Net Profit Margin (%) |
13.21 |
16.07 |
14.28 |
14.69 |
14.62 |
|
| Return on Networth / Equity (%) |
12.25 |
15.73 |
14.50 |
16.02 |
16.55 |
|
| Return on Capital Employed (%) |
16.07 |
20.34 |
19.89 |
21.93 |
22.12 |
|
| Return on Assets (%) |
10.33 |
13.32 |
12.41 |
12.98 |
13.76 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.83 |
0.90 |
0.91 |
0.97 |
1.03 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
4.71 |
4.85 |
5.09 |
3.91 |
4.17 |
|
| Quick Ratio (X) |
3.97 |
4.01 |
4.12 |
3.10 |
3.57 |
|
| Inventory Turnover Ratio (X) |
2.75 |
2.73 |
2.48 |
2.80 |
2.45 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
3.22 |
4.12 |
4.33 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
2.89 |
3.66 |
3.87 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
96.78 |
95.88 |
95.67 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
97.11 |
96.34 |
96.13 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,082.75 |
1,160.22 |
646.55 |
606.63 |
437.02 |
|
| EV/Net Operating Revenue (X) |
1.74 |
2.00 |
1.27 |
1.29 |
1.06 |
|
| EV/EBITDA (X) |
8.73 |
8.64 |
5.79 |
5.75 |
4.96 |
|
| MarketCap/Net Operating Revenue (X) |
1.77 |
2.02 |
1.33 |
1.32 |
1.09 |
|
| Retention Ratios (%) |
0.00 |
96.77 |
95.87 |
95.66 |
0.00 |
|
| Price/BV (X) |
1.64 |
1.98 |
1.35 |
1.44 |
1.23 |
|
| Price/Net Operating Revenue |
1.77 |
2.02 |
1.33 |
1.32 |
1.09 |
|
| Earnings Yield |
0.07 |
0.08 |
0.11 |
0.11 |
0.13 |
|
Source : Dion Global Solutions Limited
